Bittium Oyj (LON:0JG5)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 1.07B +371.1% |
| Revenue (ttm) | 104.51M +40.4% |
| Net Income | 18.58M +193.1% |
| EPS | 0.52 +193.0% |
| Shares Out | n/a |
| PE Ratio | 57.83 |
| Forward PE | 48.61 |
| Dividend | 0.08 (0.24%) |
| Ex-Dividend Date | May 8, 2025 |
| Volume | 4,347 |
| Average Volume | 8,137 |
| Open | 37.20 |
| Previous Close | 35.60 |
| Day's Range | 35.05 - 37.20 |
| 52-Week Range | 6.44 - 43.40 |
| Beta | 0.68 |
| RSI | 60.70 |
| Earnings Date | Mar 31, 2026 |
About Bittium Oyj
Bittium Oyj provides solutions for communications and connectivity, healthcare technology products and services, and biosignal measuring and monitoring in Finland, Germany, and the United States. It offers medical technologies products and solutions, including holter, long-term cardiac, and cardiac event monitoring; mobile cardiac telemetry; tools for biosignal analysis; medical service platform solutions; home sleep apnea testing; EEG monitoring for ICU and ER; and neuroscientific research, as well as Bittium Faros, HolterPlus, MedicalSuite, c... [Read more]
Financial Performance
In 2025, Bittium Oyj's revenue was 119.80 million, an increase of 40.40% compared to the previous year's 85.33 million. Earnings were 21.30 million, an increase of 193.11%.
Financial numbers in EUR Financial StatementsNews
Q4 2025 Bittium Oyj Earnings Call Transcript
Q4 2025 Bittium Oyj Earnings Call Transcript
